Mail

UK markets close in 4 hours 42 minutes

FTSE 100
8,105.64
+26.78(+0.33%)
FTSE 250
19,817.28
+215.30(+1.10%)
AIM
755.62
+2.50(+0.33%)
GBP/EUR
1.1660
+0.0003(+0.03%)
GBP/USD
1.2512
+0.0001(+0.01%)
Bitcoin GBP
51,342.96
+512.45(+1.01%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Q BioMed Inc. (QBIO)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0002

0.0000

(0.00%)

At close: 02:32PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	29.02k
Enterprise value	9.28M
Trailing P/E	N/A
Forward P/E	111.11
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.06
Price/book (mrq)	N/A
Enterprise value/revenue	44.34
Enterprise value/EBITDA	11.43

Trading information

Stock price history

Beta (5Y monthly)	81.00
52-week change ³	-98.35%
S&P500 52-week change ³	21.08%
52-week high ³	0.0155
52-week low ³	0.0001
50-day moving average ³	0.0002
200-day moving average ³	0.0010

Share statistics

Avg vol (3-month) ³	23.59k
Avg vol (10-day) ³	162
Shares outstanding ⁵	145.1M
Implied shares outstanding ⁶	145.1M
Float ⁸	140.88M
% held by insiders ¹	2.99%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	2.5:1
Last split date ³	07 Aug 2015

Financial highlights

Fiscal year

Fiscal year ends	30 Nov 2022
Most-recent quarter (mrq)	28 Feb 2023

Profitability

Profit margin	-231.77%
Operating margin (ttm)	-1,302.56%

Management effectiveness

Return on assets (ttm)	-85.13%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	209.29k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-2.68M
Net income avi to common (ttm)	-1.91M
Diluted EPS (ttm)	-0.0200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	23.17k
Total cash per share (mrq)	0
Total debt (mrq)	4.08M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.00
Book value per share (mrq)	-0.09

Cash flow statement

Operating cash flow (ttm)	2.18M
Levered free cash flow (ttm)	1.96M